BIIBNASDAQHealthcare

Biogen (BIIB) seasonality

Biogen Inc · 34 complete years · data through

$253.40 +1.17%

Last close · Fri, Nov 13

Your Call
Key takeaway

Biogen Inc (BIIB) seasonality: across 34 complete years (1992–2025), BIIB's strongest month has been October (average +6.1%, higher in 19 of 34 years) and its weakest March (average −2.4%, higher in 16 of 34 years). Over the 20 trading sessions after , it rose in 23 of 34 past years, with an average move of +3.6%. Data through . Historical averages, not a forecast.

Strongest monthOctober+6.1% avg · up 19 of 34 yrsWeakest monthMarch−2.4% avg · up 16 of 34 yrs
Next 4 weeksHistorically strongUp 23 of 34 yrs · +3.6% avg
Year to date+44.0%Typical by now: +25.1%
Multi-year cycleNo reliable cycleChance it's luck 25%
History34 yrsSince Sep 1991 · to Nov 13

Historical averages from daily closing prices, not a forecast and not investment advice. Disclaimer · Methodology

BIIB seasonality at a glance

BIIB average return by calendar month, 1992–2025 (month-end closes, complete years, price only).
MonthAverageMedianYears higherBest yearWorst year
January+4.0%+3.6%19 of 34 (56%)+30.3% (2000)−20.1% (1993)
February−0.2%−2.1%14 of 34 (41%)+48.7% (1995)−40.5% (2005)
March Worst−2.4%−0.1%16 of 34 (47%)+19.0% (2003)−30.5% (2000)
April−2.1%−2.3%11 of 34 (32%)+32.9% (2011)−34.6% (2000)
May+3.4%+3.8%21 of 34 (62%)+26.8% (1997)−21.9% (2002)
June+1.6%−1.0%16 of 34 (47%)+84.0% (2000)−36.2% (1994)
July+3.5%+3.7%23 of 34 (68%)+28.6% (1999)−33.0% (1996)
August+3.1%+2.7%20 of 34 (59%)+50.8% (1996)−27.0% (2008)
September+2.3%+0.3%17 of 34 (50%)+38.0% (1997)−25.9% (1999)
October Best+6.1%+4.2%19 of 34 (56%)+50.4% (1995)−16.6% (2009)
November Now+2.9%+4.2%21 of 34 (62%)+19.2% (2013)−28.5% (2002)
December+3.3%−1.3%15 of 34 (44%)+55.0% (1999)−23.2% (2007)

Current seasonal picture · November 13, 2026

As of November 13, 2026, Biogen Inc is +44.0% year to date. Across 34 complete years (1992–2025), the average at this point of the year was +25.1%, so BIIB is running ahead of its seasonal average by 18.8 percentage points. A year ago on the same date it was +7.7% year to date.

Over the next 20 trading days (about four weeks) from this date, BIIB historically averaged +3.6% (median +4.4%) and rose in 23 of 34 years (68%). Best: +31.2% in 1998; worst: −17.4% in 2002. For comparison, SPY (the S&P 500) averaged +1.3% over the same window, up in 23 of 32 years, so BIIB's seasonal edge over the market for this window is +2.3%.

In the last 20 sessions, BIIB moved in the same direction as its seasonal average on 11 of 20 days (55%), close to the 50% you would expect by chance.

Within the next 60 days, the historically strongest 10-session window began around January 2 (average +5.1%, up in 11 of 18 years) and the weakest around December 5 (average −0.5%, up in 16 of 34 years).

Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.

Next trading week (Monday to Friday): will BIIB close up, flat or down?

A free poll for fun and research: no stakes, no prizes, not advice. One vote per person per week; you can change it until the week starts. Results are scored from closing prices after the week ends. All results · My calls

BIIB seasonal charts

Choose a view

BIIB

Seasonality by calendar date

Day of year·Method 1 of 3

Each line is one calendar year of Biogen Inc, measured as its return since the previous year's final close (year to date) and drawn on a common January-to-December axis. The bold average line shows where BIIB has typically stood on each date across every complete year on file.

How the average is built. Returns are compounded from daily closing prices. Every year counts on every date: on weekends and market holidays a year keeps its last close, so the average is never built from a different mix of years on different days. Only complete calendar years enter the average, so a partial current year or a mid-year listing cannot distort it. This view surfaces date-anchored effects such as tax-loss selling into December, the January effect, quarter-end rebalancing and recurring earnings seasons.

Day-of-year seasonality for BIIB

The bold blue line is the multi-year average and orange is the current year; thinner coloured lines are the most recent years, and older years appear in grey when you choose All years. When the current-year line sits above the average, BIIB is ahead of its usual pace for the date. Hover any point to compare each year with the average on that day.

What the data says now · November 13, 2026

As of November 13, 2026, Biogen Inc is +44.0% year to date. Across 34 complete years (1992–2025), the average at this point of the year was +25.1%, so BIIB is running ahead of its seasonal average by 18.8 percentage points. A year ago on the same date it was +7.7% year to date.

This year's path so far has a correlation of 0.92 with the seasonal average (1 would be a perfect match, 0 no relationship), so 2026 has broadly followed the typical seasonal shape.

The past years whose path most resembled 2026 up to this date: 1995 (next 20 sessions: +5.4%), 2007 (next 20 sessions: +7.1%), 1999 (next 20 sessions: +6.9%).

Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.

BIIB

Seasonality by week and weekday

Day of week·Week 1–53·Method 2 of 3

Here each session is placed by its week number and weekday instead of its date. Weeks run Sunday to Saturday and week 1 is the week that contains January 1. Because calendar dates shift by a day or two each year, week numbers line up comparable sessions: week 14 ran from Monday, April 1 to Friday, April 5 in 2024, from March 31 to April 4 in 2025 and from March 30 to April 3 in 2026. Comparing "week 14, Monday" across years therefore compares the first Monday of the second quarter each time, which a fixed date such as April 1 cannot do.

Use this view for weekday tendencies (soft Mondays, strong Fridays) and to see how a pattern drifts week by week through the year. Each point is the year-to-date return at that week and weekday, averaged across complete years.

Loading the current session…

Year-to-date path by week number and weekday

Each line is one year building through the weeks; the bold line is the average. Where the yearly lines bunch together, the pattern repeated year after year; where they fan out, that stretch of the calendar was driven by events rather than the season. Labels read "week - weekday", for example "14 - Mon".

What the data says now · November 13, 2026

Over the last ten years, BIIB's strongest weekday was Wednesday (average +0.20%, up on 50% of Wednesdays) and its weakest was Thursday (−0.29%, up on 47%). Differences this small are easily swamped by news, so read them as tendencies, not rules.

For the coming week (the next 5 sessions from November 13, 2026), BIIB historically averaged −0.3% and rose in 16 of 34 years.

In the last 8 completed weeks, the weekly move matched the direction of the seasonal average in 3 of 8.

Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.

BIIB

Seasonality by trading day of the month

Trading day index·Method 3 of 3

Sessions are numbered by their position inside each month: trading day 1 is the first session of the month, day 2 the second, whatever the calendar date. Most months have 19 to 23 sessions. Lining months up this way exposes flow-driven effects that calendar dates blur, such as pension and payroll inflows around the turn of the month, mid-month options expiry and fund rebalancing in the final sessions.

The chart runs from the first trading day of January to the last trading day of December, so each point is the year-to-date return after that session. On the axis, trading day N of a month is drawn at day N of that month.

Year-to-date path by trading day of the month for BIIB

Steps that recur at the same point of every month, a rise over the first few sessions or a dip before month-end, are the signature of flows rather than news. Compare the slope of the average around the start and end of each month with the middle weeks.

What the data says now · November 13, 2026

After 10 trading days of November, BIIB is −0.1% month to date. At the same point of November in past years it averaged +0.6% (median +1.3%, up in 18 of 34 years).

Turn of the month: over the last ten years, the last two and first three trading days of each month averaged +0.24% per day, versus −0.06% on the other days, the classic month-end inflow pattern.

Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.

BIIB

BIIB seasonality vs the S&P 500

Relative seasonality·Agreement of methods

BIIB seasonality compared with the S&P 500 (SPY)

Both lines are average year-to-date returns over the same complete years, so the comparison is like for like. The dashed line is the gap: when it rises, BIIB has typically outperformed the market over that stretch of the calendar; when it falls, it has typically lagged. A stock with a strong seasonal line can still trail the market if SPY rises even more in the same weeks.

Measured over the same 32 complete years (1994–2025), BIIB's average calendar year ended +46.6% against +10.3% for SPY. The month in which BIIB typically gained most on the market was Dec (+13.1% relative), and the month it typically lost most ground was Apr (−2.6%).

Show the numbers
Average year-to-date return at each month end, BIIB vs SPY, same complete years
End ofBIIBSPYGap
Jan+4.3%+0.7%+3.5%
Feb+4.9%+0.9%+4.1%
Mar+3.2%+1.4%+1.8%
Apr+2.4%+3.2%−0.8%
May+5.3%+4.2%+1.1%
Jun+8.3%+4.4%+3.9%
Jul+12.1%+6.0%+6.1%
Aug+15.6%+5.8%+9.8%
Sep+18.4%+5.1%+13.3%
Oct+27.1%+6.8%+20.4%
Nov+32.8%+9.6%+23.2%
Dec+46.6%+10.3%+36.3%

Calendar date vs week and weekday vs trading day of the month

The averages from methods 1, 2 and 3 above, placed on one calendar axis (week slots and trading days are drawn on the dates they fell on in 2021). Lines that overlap mean the seasonal pattern holds however you count the sessions; a gap shows where an effect depends on the counting, typically around month ends and holidays.

All three methods measure the same thing, the average year-to-date return across 34 complete years, but line the sessions up differently. For BIIB they diverge noticeably at times: the largest gap between them is 9.8 percentage points around December 17. Where the lines separate, the effect depends on how you count (by date, by weekday or by session of the month); where they overlap, the pattern is robust to the method.

Show the numbers
Average year-to-date return at each month end by the three methods
End ofCalendar dateWeek & weekdayTrading day
Jan+4.0%+4.2%+3.8%
Feb+4.3%+5.8%+4.2%
Mar+1.6%+1.4%+1.6%
Apr−0.2%+0.4%−0.2%
May+2.8%+2.3%+2.8%
Jun+5.3%+6.2%+5.3%
Jul+8.7%+6.7%+8.7%
Aug+12.2%+13.6%+12.1%
Sep+14.6%+13.9%+14.6%
Oct+23.7%+26.1%+21.8%
Nov+29.4%+30.2%+29.4%
Dec+41.9%+41.9%+41.9%

BIIB monthly returns heatmaps

Intraday momentum. Each cell sums the daily open-to-close percent changes inside that month, leaving out the overnight gaps between one close and the next open. Compare it with the next heatmap to see whether a month's gains came during trading hours or overnight. Very old years can show 0.00 where the data source recorded a single price per day.

Held through the month. Each cell is the change from the first session open to the last session close — the return of entering on day one and exiting on the final bar.

BIIB earnings, revenue and company events

Earnings reaction history · 87 reports since Oct 2004

On the first trading session after its earnings releases, BIIB closed higher 47 of 87 times (54%), with a typical move of ±3.3%. Average reaction by fiscal quarter: Q1 +0.4% (up 10 of 22) · Q2 +0.6% (up 16 of 22) · Q3 −0.8% (up 9 of 21) · Q4 +0.5% (up 12 of 22).

Across 86 reports with full windows, the stock moved +0.5% on average in the 15 sessions before the report and +0.7% in the 15 sessions after the reaction day.

The latest report was released on October 28, 2026 (before the open) for fiscal Q3 2026; the stock moved −3.43% on the reaction day.

Report dates and actual EPS come from the company's SEC filings; price moves from daily closes. Analyst estimates are not shown. Past reactions do not predict the next one. Reports before late 2004 are not included: companies have flagged earnings releases in SEC filings (Form 8-K, Item 2.02) only since August 2004, while BIIB's price history goes back to 1991.

Post-earnings price move: the last 12 reports and the average

0 is the first session after the release; each line is the change from the close before it. Thin lines are single reports, coloured by fiscal quarter (solid = latest, dashed = a year earlier, dotted = two years earlier); the thick line is the average of all reports. Use the buttons to switch to averages by quarter, or click any legend item.

BIIB earnings history: report dates, EPS and post-earnings price moves (latest first). Reaction = close of the first session after the release vs the close before it.
ReleasedTimingFiscal quarterEPS (diluted)EPS vs year agoReaction day15 sessions before15 sessions after
Oct 28, 2026Before openQ3 2026$-0.14−104%−3.43%+13.4%–
Jul 29, 2026Before openQ2 2026$0.66−85%+1.76%−0.0%+5.9%
Apr 29, 2026Before openQ1 2026$2.15+31%+6.00%+4.4%−3.4%
Feb 6, 2026Before openQ4 2025$-0.35*–+8.53%+9.5%−6.5%
Oct 14, 2025After closeQ3 2025$3.17+19%−1.14%+4.3%+6.8%
Jul 31, 2025Before openQ2 2025$4.33+8%+1.07%−4.8%+8.7%
May 1, 2025Before openQ1 2025$1.64−39%−0.12%+6.2%+4.4%
Feb 12, 2025Before openQ4 2024$1.82*–−4.28%−1.1%+10.5%
Oct 30, 2024Before openQ3 2024$2.66–−1.25%+0.6%−13.9%
Aug 1, 2024Before openQ2 2024$4.00−2%−1.17%−8.4%−3.5%
Apr 24, 2024Before openQ1 2024$2.70+1%+4.56%−7.0%+16.5%
Feb 13, 2024Before openQ4 2023$1.70*–−7.39%−1.4%−4.0%

* Q4 EPS derived from the annual figure minus the first three quarters. EPS as reported by the company; not adjusted for later stock splits.

Where the revenue comes from · as reported to the SEC

BIIB reports its revenue by 12 product and service lines. Latest: $2.8B in the quarter ending Sep 2026, +11% from a year earlier.

Figures are from BIIB’s own 10-Q and 10-K financial statements (XBRL), as reported, not adjusted. Products, segments and regions are the company’s own groupings and can change when it reorganises; only periods comparable with the latest are shown. * Fourth quarter = fiscal year minus the first nine months.

BIIB revenue by product and service

In the quarter ending Sep 2026, Revenue from anti-CD20 therapeutic programs brought in $497M, 18% of BIIB’s $2.8B revenue. Compared with a year earlier, Skyclarys grew fastest (+34%) and Avonex shrank most (−17%).

BIIB revenue by products & services, latest quarter (new grouping). Share and change are for the latest quarter.
Quarter endingSep ’26Sharevs year before
Revenue from anti-CD20 therapeutic programs$497M18%—
Spinraza$461M16%—
Fumarate$274M10%—
Specialized Immunology$243M9%—
Interferon$208M7%−16%
Vumerity$192M7%−11%
Syfovre$191M7%—
Skyclarys$178M6%+34%
Avonex$157M6%−17%
Contract manufacturing, royalty and other revenue$150M5%−1%
Contract manufacturing revenue$136M5%−4%
Benepali$117M4%−4%
Total revenue$2.8B100%+11%
Fiscal years
BIIB revenue by products & services, fiscal years. Share and change are for the latest year.
Fiscal year endingDec ’25Sharevs year before
Spinraza$1.5B16%—
Fumarate$1.4B14%—
Royalty Attributed To OCREVUS$1.4B14%—
Vumerity$747M8%+19%
Contract Manufacturing Royalty and Other Revenue$733M7%+12%
Biosimilars$729M7%−8%
Avonex$696M7%−2%
Tecfidera$680M7%−30%
Contract manufacturing revenue$679M7%+15%
Skyclarys$521M5%+36%
Benepali$453M5%—
Plegridy$250M3%−4%
Total revenue$9.9B100%+2%

Company events · from 175 SEC 8-K filings since 2004

In the last five years BIIB filed 32 event reports, including 5 deals, 11 leadership, 5 results updates. On the days after major events (deals completed, restructurings, write-downs and similar) the stock moved 6.4% on average in either direction, against 1.4% on a typical day. Latest major event: completed an acquisition or sale of assets on May 14, 2026 (−6.4% the next session).

From the item codes companies must use when filing a Form 8-K with the SEC. Under each event type is a one-line extract of what the filing says, picked out of the filing text automatically (not written or checked by an editor); open the filing for the full wording. Quarterly earnings releases are in the section above.

BIIB events from SEC Form 8-K filings, latest first. Move = close of the first session that could react vs the close before.
FiledEventNext-session moveSource
Results updateBiogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the second quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $164 million on a pre-tax basis.+3.04%SEC filing
Shareholder vote resultsBiogen Inc. held its 2026 Annual Meeting of Stockholders. The final voting results for this meeting are as follows.+2.94%SEC filing
Completed an acquisition or sale of assets · Signed a material agreement · New debt or financing · Investor presentation or announcementPursuant to the Merger Agreement, on April 14, 2026, Purchaser commenced a tender offer to acquire any and all of the issued and outstanding Shares, in exchange for (i) $41.00 per Share, net to the seller in cash, without interest and…−6.43%SEC filing
Results updateBiogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the first quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $34 million on a pre-tax basis.−2.82%SEC filing
Signed a material agreement · Other company newsBiogen Inc. entered into an Agreement and Plan of Merger with Apellis Pharmaceuticals, Inc. and Aspen Purchaser Sub, Inc. and a wholly owned subsidiary of Biogen.+0.25%SEC filing
Executive or board changeBiogen Inc. announced that Susan H. Alexander, Chief Legal Officer, will depart from the Company effective as of the end May, 2026.−2.93%SEC filing
Executive or board change · Other company newsCaroline Dorsa, Chair of the Biogen Inc. Board of Directors announced that she would not stand for re-election to the Board at the 2026 Annual Meeting of Stockholders.+2.25%SEC filing
Results updateBiogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the fourth quarter of 2025 will include acquired in-process research and development, upfront and milestone expense of approximately $222 million on a pre-tax basis.−5.04%SEC filing
Results updateAnnounced its results of operations and financial condition for the third quarter ended September 30, 2025.+1.18%SEC filing
Results updateBiogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the second quarter of 2025 will include acquired in-process research and development, upfront and milestone expense of approximately $46 million on a pre-tax basis.+3.33%SEC filing
Shareholder vote resultsBiogen Inc. held its 2025 Annual Meeting of Stockholders. The final voting results for the Annual Meeting are as follows: 1.Stockholders elected eleven nominees to the Board of Directors to serve for a one-year term extending until the…+1.24%SEC filing
Other company newsBiogen Inc. entered into an Underwriting Agreement with BofA Securities, Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named in Schedule I thereto, relating to the…−1.00%SEC filing
Executive or board changeBiogen Inc. appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated Mr. Godbout as the Company’s principal accounting officer, in each case effective as of March 1, 2025.−1.44%SEC filing
Executive or board change · Investor presentation or announcementMichael McDonnell, Chief Financial Officer of Biogen Inc. notified the Company that he will retire from the Company effective February 28, 2025.−3.96%SEC filing
Executive or board changeThe Board of Directors of Biogen Inc. increased the size of the Board and elected Lloyd B. Minor, M.D. and Sir Menelas (Mene) Pangalos, Ph.D. as directors, effective October 1, 2024 and January 1, 2025, respectively, with each director’s…−0.60%SEC filing

BIIB price history and multi-year cycles

Daily percent change, September 17, 1991 to November 13, 2026

Close is plotted by default. Add open, high, low or volume from the legend, and drag across the chart to zoom into any period.

Stock market cycle · 34 complete years, monthly closes since Sep 1991

No reliable multi-year cycle. The strongest repeating swing around BIIB's long-term trend lasts about 4.4 years from peak to peak, moving the price roughly ±24% around the trend and explaining 18% of the swings. Random price wandering with the same persistence produces a cycle at least that strong in ~25% of simulations, so it could easily be chance.

Using swings of 35% or more (scaled to its volatility of 49% a year), BIIB made 14 major peaks and 14 major troughs. Peaks came every 2.0 years (median; range 0.7–7.4), troughs every 2.1 years. The spacing is irregular, so the gaps are not a reliable clock. Typical drawdown: −52% over 10 months; typical recovery to the next peak: 18 months.

Latest major turning point: a trough in Apr 2025, 19 months ago; the price has moved +109% since and is −35% from its all-time high.

8 of its 14 major drawdowns overlapped a broad S&P 500 sell-off or bear market (within three months), a mix of market-wide and company-specific falls. Its swings around trend move partly with the Dow's (correlation 0.40 over 35 years); the Dow's own strongest cycle is about 3.5 years. Calendar-year returns show no meaningful year-to-year memory: one year's result has said little about the next.

Since 2009, reported EPS was below the year-earlier quarter in 19 of 63 quarters. Earnings down-cycles of two or more quarters began in Jan 2017 (3 quarters, price +12%), Oct 2020 (6 quarters, price −23%), Jul 2023 (2 quarters, price −16%), Jul 2026 (ongoing, 2 quarters, price +19%). They started every 3.0 years (median).

Computed from monthly closes (not adjusted for dividends): trend = 10-year local regression of log price; cycle = best sine fit from 2 to 8 years, tested against 120 red-noise simulations; turning points use a volatility-scaled reversal threshold; EPS from SEC filings. Past cycles do not predict future prices; this is not investment advice.

BIIB stock cycle: price vs long-term trend, with major peaks and troughs

The blue line is how far the monthly close sat above (+) or below (−) its 10-year trend; triangles mark the major turning points; grey bands are S&P 500 bear markets and crashes. Drag the panel below the chart to zoom.

BIIB presidential election cycle: calendar-year return by year of the U.S. presidential term (complete years), with the Dow in the same years.
Term yearYearsAverage returnUp yearsDow, same years
Post-election year9+14.0%6 of 9+14.5%
Midterm year8−1.5%5 of 8+2.7%
Pre-election year8+149.6%5 of 8+16.2%
Election year9+12.7%4 of 9+3.8%
Show all 14 drawdowns and recoveries (peak to trough)
BIIB drawdowns and recoveries (monthly closes, reversals of 35% or more), latest first.
PeakTroughDrawdownMonths downRecovery to next peakMonths upDuring S&P 500 sell-off
Nov 2022Apr 2025−60%29+109% (so far)19+Yes
Jun 2021Aug 2022−44%14+56%3Yes
Aug 2018May 2019−38%9+58%25Yes
Mar 2015Jun 2016−43%15+59%26No
Oct 2007Oct 2009−43%24+902%65Yes
Dec 2004Jun 2005−48%6+116%28No
Nov 2001Feb 2003−59%15+132%22Yes
Oct 2000Mar 2001−39%5+76%8Yes
Feb 2000May 2000−55%3+208%5Yes
Feb 1998Aug 1998−60%6+1,467%18Yes
Apr 1996Jul 1996−46%3+193%19No
Jan 1994Dec 1994−67%11+1,242%16No
Nov 1992Jul 1993−64%8+72%6No
Sep 1991Sep 1992−65%12+61%2No

What if you had traded BIIB by simple rules?

$10,000 in BIIB · January 2008 to Nov 13, 2026

Buy and hold$49,242+8.8% a year
Trading hours only$23,852+4.7% a year · trailed holding
Overnight only$20,267+3.8% a year · trailed holding
Up-signal days only$11,374+0.7% a year · trailed holding
Sit out down-signal days$20,894+4.0% a year · trailed holding

Trading hours vs overnight

More of BIIB's gains came during trading hours: owning it only from open to close turned $10,000 into $23,852, owning it only from close to the next open into $20,267. Together they make up buy and hold ($49,242).

Did the seasonal signal help? No clear edge

Average open-to-close move: +0.027% on the 1,244 days when all three methods pointed up, +0.036% on all days, +0.068% on the 694 down-signal days. Holding from the previous close to the next open: +0.07% around up-signal days vs +0.09% on any day.

Hypothetical results from daily open and close prices since January 2008 (earlier prices are rounded too coarsely for open-based tests), price only: dividends are not added back, and because a stock drops by its dividend at the open on the ex-dividend date, overnight results of dividend payers are understated by roughly their dividend yield; no taxes. The "after costs" column deducts 0.05% per trade; real spreads, commissions and slippage can be larger, which matters most for daily rules. Seasonal signals use only data from years before each trade. Past results do not predict future results. Study: these rules across 293 stocks and ETFs.

$10,000 invested in BIIB under each rule, January 2008 to date. Green: ended above buy and hold. Shaded rows use the seasonal signal.
Rule$10,000 becamePer yearLast 10 yrs, per yearTradesWinning tradesAverage tradeWorst drawdownAfter 0.05% per trade
Open to close, every dayBuy at each open, sell at the same day's close (trading hours only)$23,852+4.7%−5.1%4,74749%+0.04%−87%$2,221
Close to next open, every dayBuy at each close, sell at the next open (overnight only)$20,267+3.8%+3.7%4,74652%+0.03%−71%$1,888
Open to next openBuy at the open, sell at the next session's open$47,802+8.6%−1.6%4,74649%+0.06%−75%$4,453
Close to close (buy and hold)Buy at the close, sell at the next close: the same as holding$49,242+8.8%−1.5%4,74651%+0.06%−74%$4,587
Each week, open to closeBuy the week's first open, sell its last close (out over weekends)$46,568+8.5%+0.1%98553%+0.27%−70%$28,454
Each month, open to closeBuy the month's first open, sell its last close$46,818+8.5%−1.7%22751%+1.08%−74%$41,794
Each year, open to closeBuy the year's first open, sell its last close$32,176+6.4%−4.0%1850%+10.30%−52%$31,888
Up-signal days, open to closeOn each day when all three seasonal methods point up: buy at that day's open, sell at its close. Otherwise in cash.$11,374+0.7%−1.3%1,24449%+0.03%−40%$6,106
Up-signal days, close before to open afterBuy at the close the day before an up-signal day, sell at the open the day after it. Back-to-back signal days are held as one trade.$11,014+0.5%−1.5%85553%+0.06%−57%$7,182
Hold, but sit out down-signal daysHold all the time, except: sell at the close before a day when all three methods point down, stay in cash through that day (and any down days right after it), buy back at the close of the last one.$20,894+4.0%−2.9%53353%+0.30%−77%$16,005

Growth of $10,000 under each rule (log scale)

Each line is the value of $10,000 following one rule from January 2008. On a log scale, equal slopes mean equal percentage growth. Click the legend to add the weekly, monthly and other seasonal rules.

Do the three seasonal methods pick better days for BIIB? Average result per day, by what the methods said beforehand.
Day typeDaysOpen to closeUp daysPrevious close to next openUp
All three methods up1,244+0.027%49%+0.07%51%
All three methods down694+0.068%51%+0.14%52%
All days4,747+0.036%49%+0.09%51%

BIIB seasonality data tables

Trading days8,852Daily sessions in the dataset
CoverageSep 1991 – Nov 202636 calendar years
Latest closeNov 13, 2026Most recent session on file
Last refreshNov 15, 2026When the dataset last rebuilt

Updated This BIIB seasonality chart is built from 8,852 trading days of historical data, spanning from through — covering 36 years of market activity.

Biogen Inc · NASDAQ · Prices adjusted daily. Past seasonality is not a forecast.

Sessions traded per month for BIIB. Months with more sessions carry more weight in every seasonal average below.

Year-by-year performance for Biogen Inc, so a seasonal pattern can be read against the trend it sits inside.

Each cell is that year's year-to-date return (%) at the close of that date, compounded from the previous year's final close. Average Value is the mean across complete years. A blank cell means the market was closed that day or the data begins later.
One row per week number and weekday. Each year column is that year's year-to-date return (%) at that session; Average Value is the mean across complete years.

How to read this BIIB seasonality page

BIIB

BIIB seasonality FAQ

Methodology·8,852 sessions
What is the best month for BIIB stock?

Historically October: across 34 complete years (1992–2025) BIIB averaged +6.1% in October and finished the month higher in 19 of 34 years. Its weakest month has been March (average −2.4%, higher in 16 of 34 years).

How has BIIB performed in the next four weeks historically?

In the 20 trading sessions after November 13, BIIB rose in 23 of 34 past years, with an average move of +3.6% and a median of +4.4%. This is a historical record, not a forecast.

What is BIIB seasonality?

Seasonality is the tendency of a stock or fund to behave differently at particular points of the calendar. This page measures it for Biogen Inc three ways (by calendar date, by week and weekday, and by trading day of the month) across 8,852 trading sessions.

How are the seasonal averages calculated?

From daily closing prices, compounded rather than added, so a 10% gain followed by a 10% loss counts as the 1% loss it really is. Each year's year-to-date return is carried over weekends and holidays, and only complete calendar years enter the averages. Prices are adjusted for splits but not for dividends.

Why do the three seasonality methods sometimes disagree?

They line the data up differently. A calendar date falls on a different weekday and a different trading day of the month every year, so an effect driven by month-end flows shows clearly by trading day and only faintly by date. Agreement across all three is the stronger signal.

How current is the data?

Prices are refreshed automatically after each trading session and checked for gaps, duplicates, bad prints and unadjusted splits. The latest session on file is November 13, 2026.

Can seasonality be traded on its own?

No. These are historical averages over a limited number of years, and any single year can differ completely. Treat a seasonal pattern as context for a decision you have other reasons to make, and read the disclaimer.

Full method: how SeasonalityCharts measures seasonality · Disclaimer

Data last refreshed November 13, 2026. Seasonality figures are historical averages drawn from 8,852 trading sessions; they are not a forecast, and nothing on this page is investment advice. Please do your own research and see the Disclaimer.